Sickle Cell Disease

References

Citations

1. Gladwin MT, et al. (2004). Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. New England Journal of Medicine, 350(9): 886–95.

2. Hirst C, Wang WC (2001). Blood transfusion for preventing stroke in people with sickle cell disease. Cochrane Database of Systematic Reviews (1). Oxford: Update Software.

3. Steinberg MH (2008). Sickle cell disease and associated hemoglobinopathies. In L Goldman, D Ausiello, eds., Cecil Medicine, 23rd ed., pp. 1217–1226. Philadelphia: Saunders Elsevier.

4. Wang WC (2004). Sickle cell anemia and other sickling syndromes. In JP Greer et al., eds., Wintrobe's Clinical Hematology, 11th ed., pp. 1264–1311. Philadelphia: Lippincott Williams and Wilkins.

5. National Heart, Lung, and Blood Institute, National Institutes of Health (2002). The Management of Sickle Cell Disease (NIH Publication No. 02-2117). Available online: http://www.nhlbi.nih.gov/health/prof/blood/sickle/.

6. Goldstein LB, et al. (2006). Primary prevention of ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council. Stroke, 37(6): 1583–1633.

7. American Academy of Pediatrics, et al. (2003, reaffirmed 2007). Policy statement: Eye examination in infants, children, and young adults by pediatricians. Pediatrics, 111(4): 902–907.

8. Committee on Genetics, American Academy of Pediatrics (2002). Health supervision for children with sickle cell disease. Pediatrics, 109(3): 526–535.

Other Works Consulted

• Brawley OW, et al. (2008). National Institutes of Health consensus development conference statement: Hydroxyurea treatment for sickle cell disease. Annals of Internal Medicine, 148(12): 932–938.

• De Montalembert M (2008). Management of sickle cell disease. BMJ, 337(a1397): 626–630.

• Furie B, et al. (2003). Red blood cell disorders. In Clinical Hematology and Oncology: Presentation, Diagnosis, and Treatment, pp. 464–465. Philadelphia: Churchill Livingstone.

• Hillman RS, et al. (2005). Hemoglobinopathies. In Hematology in Clinical Practice, 4th ed., pp. 80–94. New York: McGraw-Hill.

• Hirst C, Owusu-Ofori S (2002). Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. Cochrane Database of Systematic Reviews (3). Oxford: Update Software.

• Jones AP, et al. (2001). Hydroxyurea for sickle cell disease. Cochrane Database of Systematic Reviews (2). Oxford: Update Software.

• Lanzkron S, et al. (2008). Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease. Annals of Internal Medicine, 148(12): 939–955.

• Meremikwu MM (2007). Sickle cell disease, search date August 2006. Online version of BMJ Clinical Evidence: http://www.clinicalevidence.com.

• Price EA, Schrier SL (2008). Hemoglobinopathies and hemolytic anemias. In DC Dale, DD Federman, eds., ACP Medicine, section 5, chap. 4. Hamilton, ON: BC Decker.

Go to previous section	Go to top of page	Go to next section
Author:	Debby Golonka, MPH	Last Updated: December 9, 2008
Medical Review:	Anne C. Poinier, MD - Internal Medicine Martin Steinberg, MD - Hematology
© 1995-2009 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.